http://www.addexpharma.com/ Latest News en TYPO3 - get.content.right http://blogs.law.harvard.edu/tech/rss Thu, 07 Aug 2008 18:00:00 +0200 http://www.addexpharma.com/press-releases/press-release-details/article/disclosure-of-shareholdings-in-accordance-with-stock-market-rules-3/ http://www.addexpharma.com/press-releases/press-release-details/article/disclosure-of-shareholdings-in-accordance-with-stock-market-rules-3/ Geneva, Switzerland, 7 August 2008 - Addex Pharmaceuticals (SWX:ADXN) announced today that on August 6, 2008, Varuma AG, Aeschenvorstadt 55, 4051 Basel, Switzerland, has informed of exceeding the threshold of 3% in the shareholding of Addex Pharmaceu... 2008 Thu, 07 Aug 2008 18:00:00 +0200 http://www.addexpharma.com/press-releases/press-release-details/article/disclosure-of-shareholdings-in-accordance-with-stock-market-rules-2/ http://www.addexpharma.com/press-releases/press-release-details/article/disclosure-of-shareholdings-in-accordance-with-stock-market-rules-2/ Geneva, Switzerland, 5 August 2008 - Addex Pharmaceuticals (SWX:ADXN) announced today that on July 31, 2008, The Swiss Helvetia Fund, Inc. 1270 Avenue of the Americas, Suite 400, New York, NY 10020, U.S.A., has informed of exceeding the threshold of ... 2008 Tue, 05 Aug 2008 19:35:00 +0200 http://www.addexpharma.com/press-releases/press-release-details/article/addex-pharmaceuticals-reports-first-half-2008-financial-results-maiden-profit/ http://www.addexpharma.com/press-releases/press-release-details/article/addex-pharmaceuticals-reports-first-half-2008-financial-results-maiden-profit/ Français (PDF)Deutsch (PDF)English (PDF) webcast & supporting documents Geneva, Switzerland, 28 July 2008 ? Addex Pharmaceuticals (SWX:ADXN) released today financial results for the first half of 2008 and gave an update on the status of its lead pr... 2008 Mon, 28 Jul 2008 07:00:00 +0200 http://www.addexpharma.com/press-releases/press-release-details/article/addex-appoints-laurent-galibert-head-of-inflammation-business-unit/ http://www.addexpharma.com/press-releases/press-release-details/article/addex-appoints-laurent-galibert-head-of-inflammation-business-unit/ Français (PDF)Deutsch (PDF)English (PDF) Geneva, Switzerland, 28 July 2008 ? Addex Pharmaceuticals is pleased to announce the appointment of Laurent Galibert to its executive management team, as head of the Addex Inflammation Business Unit. Vincent... 2008 Mon, 28 Jul 2008 06:50:00 +0200 http://www.addexpharma.com/press-releases/press-release-details/article/addex-first-half-2008-financial-results-monday-july-28/ http://www.addexpharma.com/press-releases/press-release-details/article/addex-first-half-2008-financial-results-monday-july-28/ Geneva, Switzerland, 18 July 2008 ? Addex Pharmaceuticals Ltd. (SWX:ADXN) will discuss its financial results for the first half of 2008 and give a pipeline update during a teleconference and webcast for investors, analysts and the media on Monday, Ju... 2008 Fri, 18 Jul 2008 18:29:00 +0200 http://www.addexpharma.com/press-releases/press-release-details/article/addex-starts-phase-i-adx10059-interaction-study/ http://www.addexpharma.com/press-releases/press-release-details/article/addex-starts-phase-i-adx10059-interaction-study/ New formulation of ADX10059 selected 2008 Wed, 04 Jun 2008 13:45:00 +0200 http://www.addexpharma.com/press-releases/press-release-details/article/disclosure-of-shareholdings-in-accordance-with-stock-market-rules/ http://www.addexpharma.com/press-releases/press-release-details/article/disclosure-of-shareholdings-in-accordance-with-stock-market-rules/ Geneva, Switzerland, 27 May 2008 - Addex Pharmaceuticals Ltd. (SWX:ADXN) disclosed the following shareholdings. Addex Pharmaceuticals Ltd. was informed by: Sofinnova Capital IV FCPR(1) that it holds 806,648 shares, corresponding to 13.76% of the v... 2008 Tue, 27 May 2008 13:51:00 +0200 http://www.addexpharma.com/press-releases/press-release-details/article/addex-starts-adx10059-phase-i-formulation-selection-study/ http://www.addexpharma.com/press-releases/press-release-details/article/addex-starts-adx10059-phase-i-formulation-selection-study/ English (PDF) Geneva, Switzerland, 24 April 2008 ? Addex Pharmaceuticals (SWX:ADXN) announced that it has begun Phase I testing of two formulations of ADX10059 and that it will elaborate on ADX10059 development and its pipeline during today?s R&D da... 2008 Thu, 24 Apr 2008 13:57:00 +0200 http://www.addexpharma.com/press-releases/press-release-details/article/addex-appoints-laurent-massuyeau-as-head-of-business-development/ http://www.addexpharma.com/press-releases/press-release-details/article/addex-appoints-laurent-massuyeau-as-head-of-business-development/ Français (PDF)Deutsch (PDF)English (PDF) Geneva, Switzerland, 18 April 2008 ? Addex Pharmaceuticals (SWX:ADXN) is pleased to announce the appointment of Laurent Massuyeau as head of business development.Mr. Massuyeau joins Addex from Idenix P... 2008 Fri, 18 Apr 2008 14:08:00 +0200 http://www.addexpharma.com/press-releases/press-release-details/article/addex-shareholders-elect-ray-hill-to-board-of-directors-at-the-2008-annual-general-meeting/ http://www.addexpharma.com/press-releases/press-release-details/article/addex-shareholders-elect-ray-hill-to-board-of-directors-at-the-2008-annual-general-meeting/ Shareholders Approve All Board Proposals at 2008 AGM 2008 Fri, 18 Apr 2008 11:10:00 +0200